IAS statement: IAS calls for global access as Gilead announces lenacapavir licensing General News October 3, 2024 PRESS RELEASE 3 October 2024 (Geneva, Switzerland) – IAS – the International AIDS Society – applauds moves by Gilead Sciences…
